Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

LNTH 2401

Next Previous
Search
Drug Profile

LNTH 2401

Alternative Names: 68Ga-DOTA-RM2; 68Ga-Bombesin; [(68)Ga]-labelled bombesin; [68GA]DOTA-4-AMINO-1-CARBOXYMETHYLPIPERIDINE-D-PHE-GLN-TRP-ALA-VAL-GLY-HIS-STA-LEU-NH2; [68Ga]RM2; BAY 867548; Bombesin (68Ga) labelled; Gallium-68 RM2 - Life Moleuclar Imaging; Gallium-68-bombesin; LNTH-2401

Latest Information Update: 27 Jan 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Bayer HealthCare Pharmaceuticals
  • Developer Life Molecular Imaging; National Cancer Institute (USA); Stanford University; University Hospital of Bordeaux
  • Class Imaging agents; Neuropeptides; Oligopeptides; Organometallic compounds; Radioisotopes; Radiopharmaceutical diagnostics; Radiopharmaceuticals
  • Mechanism of Action Positron-emission tomography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Prostate cancer

Most Recent Events

  • 27 Jun 2024 LNTH 2401 licensed to Lantheus Holdings worldwide
  • 07 Mar 2022 Stanford University in collaboration with General electric completes a phase I/II trial in Prostate cancer (Diagnosis) in the US (IV) (NCT03949517)
  • 05 Mar 2021 Phase-II development is ongoing in France and USA (IV)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top